Impax Laboratories buy klostergang
Start price
21.09.17
/
50%
€21.38
Target price
07.05.18
€31.57
Performance (%)
-22.78%
End price
07.05.18
€16.51
Summary
This prediction ended on 07.05.18 with a price of €16.51. The prediction for Impax Laboratories disappointed with a performance of -22.78%. klostergang has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Impax Laboratories | - | - | - | - |
iShares Core DAX® | 0.786% | 1.251% | 11.561% | 16.636% |
iShares Nasdaq 100 | 1.855% | -2.687% | 25.316% | 43.346% |
iShares Nikkei 225® | 3.947% | 2.199% | 11.527% | 12.586% |
iShares S&P 500 | 1.787% | 0.151% | 23.699% | 42.958% |
Comments by klostergang for this prediction
In the thread Impax Laboratories diskutieren
klostergang stimmt der fundamentalen Bewertung mit dem Ergebnis 'überbewertet' nicht zu
Rumor du jour: Impax Labs mulling merger with Amneal Pharma
A deal could be announced as early as next month. A takeover could boost Impax's value north of $2B
(Vom Mitglied beendet)